نتایج جستجو برای: pca diagnosis

تعداد نتایج: 489498  

2017
Masafumi Chiba Hiroo Imazu Masayuki Kato Keiichi Ikeda Hiroshi Arakawa Tomohiro Kato Kazuki Sumiyama Sadamu Homma

Specimens obtained with endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) are often tiny and fragmented leading to an inconclusive and doubtful diagnosis. To overcome the limitations of EUS-FNA in the cytological diagnosis of pancreatic adenocarcinoma (PCA), we evaluated whether quantification of the S100P protein combined with EUS-FNA reliably discriminated between PCA and benign p...

Journal: :European urology 2015
Bimal Bhindi Jennifer Locke Shabbir M H Alibhai Girish S Kulkarni David S Margel Robert J Hamilton Antonio Finelli John Trachtenberg Alexandre R Zlotta Ants Toi Karen M Hersey Andrew Evans Theodorus H van der Kwast Neil E Fleshner

BACKGROUND A biologic rationale exists for the association between metabolic syndrome (MetS) and prostate cancer (PCa). However, epidemiologic studies have been conflicting. OBJECTIVE To evaluate the association between MetS and the odds of PCa diagnosis in men referred for biopsy. DESIGN, SETTING, AND PARTICIPANTS Patients without prior PCa diagnosis undergoing prostate biopsy were identif...

Prostate cancer (PCa) is the most common type of cancer among men over 60 years old. The aggressiveness and mortality of PCa can be correlated with obesity. Adipose tissue-derived cytokines such as adiponectin may explain the correlation between PCa and obesity. Since the correlation between adiponectin and aggressive PCa is still not fully evaluated, we aimed to investigate the probable role o...

2014
Mieke Van Hemelrijck Anita Feller Hans Garmo Fabio Valeri Dimitri Korol Silvia Dehler Sabine Rohrmann

INTRODUCTION There is a need to assess risk of second primary cancers in prostate cancer (PCa) patients, especially since PCa treatment may be associated with increased risk of second primary tumours. METHODS We calculated standardized incidence ratios (SIRs) for second primary tumours comparing men diagnosed with PCa between 1980 and 2010 in the Canton of Zurich, Switzerland (n = 20,559), an...

2017
Tamara Sequeiros Marina Rigau Cristina Chiva Melania Montes Iolanda Garcia-Grau Marta Garcia Sherley Diaz Ana Celma Irene Bijnsdorp Alex Campos Primiano Di Mauro Salvador Borrós Jaume Reventós Andreas Doll Rosanna Paciucci Michiel Pegtel Inés de Torres Eduard Sabidó Juan Morote Mireia Olivan

Rapid and reliable diagnosis of prostate cancer (PCa) is highly desirable as current used methods lack specificity. In addition, identification of PCa biomarkers that can classify patients into high- and low-risk groups for disease progression at early stage will improve treatment decision-making. Here, we describe a set of protein-combination panels in urinary extracellular vesicles (EVs), def...

Journal: :Asian journal of andrology 2013
Wennuan Liu Li Wang Jianfeng Xu

C urrent clinicopathologic indicators are insufficient to distinguish the small percentage of aggressive prostate cancer (PCa) from the vast majority of indolent disease at diagnosis, leading to overtreatment of PCa. A recent study reported and confirmed a strong association of PCaspecific mortality with somatic DNA copy number alterations (CNAs) in primary prostate tumors. If a sensitive, robu...

Journal: :Oncology letters 2017
Huakang Tu Jian Gu Qing H Meng Jeri Kim Sara Strom John W Davis Yonggang He Elizabeth A Wagar Timothy C Thompson Christopher J Logothetis Xifeng Wu

Serum testosterone is a potential marker to distinguish between indolent and aggressive prostate cancer (PCa). The present study aimed to investigate whether low levels of total serum testosterone at diagnosis were associated with aggressive PCa and poor clinical outcomes. In total, 762 non-Hispanic Caucasian men with previously untreated PCa were recruited from The University of Texas MD Ander...

2013
Fu-neng Jiang Hui-chan He Yan-qiong Zhang Deng-Liang Yang Jie-Hong Huang Yun-xin Zhu Ru-jun Mo Guo Chen Sheng-bang Yang Yan-ru Chen Wei-de Zhong Wen-Liang Zhou

AIM Early diagnosis of prostate cancer (PCa), which is a clinically heterogeneous-multifocal disease, is essential to improve the prognosis of patients. However, published PCa diagnostic markers share little overlap and are poorly validated using independent data. Therefore, we here developed an integrative proteomics and interaction network-based classifier by combining the differential protei...

2010
Xue Min Tian Gong Quan Chen Yu Ping Cao Sheng Chen

A unified framework based on the dynamic principal component analysis (PCA) is proposed for performance monitoring of constrained multi-variable model predictive control (MPC) systems. In the proposed performance monitoring framework, the dynamic PCA based performance benchmark is adopted for performance assessment, while performance diagnosis is carried out using a unified weighted dynamic PCA...

Journal: :European urology 2015
Axel Gerdtsson Jessica B Poon Daniel L Thorek Lorelei A Mucci Michael J Evans Peter Scardino Per-Anders Abrahamsson Peter Nilsson Jonas Manjer Anders Bjartell Johan Malm Andrew Vickers Stephen J Freedland Hans Lilja David Ulmert

BACKGROUND Previous studies of prostate cancer (PCa) risk and anthropometrics (ie, body measurements) were based on single measurements or obtained over limited time spans. OBJECTIVE To study the association between anthropometrics measured at multiple time points in life and their relation to later diagnosis, metastasis, or death from PCa. DESIGN, SETTING, AND PARTICIPANTS This case-contro...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید